Challenges in understanding Sjögren's syndrome - improved insights into the pathogenesis generate hope for innovative therapies?

Arthritis Research and Therapy

Volumn 13, Issue 4, 2011, Pages

  Dörner, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; CD20 ANTIBODY; INTERFERON; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

CANCER RISK; EDITORIAL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOMA; NONHUMAN; PATHOGENESIS; RETROVIRUS; SJOEGREN SYNDROME; VIRUS ETIOLOGY;

EID: 80052225632     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3425     Document Type: Editorial

References (12)

1. Jacob N, Stohl W. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther 2011, 13:228. 10.1186/ar3349, 21745419.
2. Shao WH, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther 2011, 13:202.
3. Holle JU, Moosig F, Dalhoff K, Gross WL. Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides. Arthritis Res Ther 2011, 13:224. 10.1186/ar3307, 21722330.
4. Sipsas NV, Gamaletsou MN, Moutsopoulos HM. Is Sjögren's syndrome a retroviral disease?. Arthritis Res Ther 2011, 13:212. 10.1186/ar3262, 21489323.
5. Vitali C. Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res Ther 2011, 13:233.
6. Low H, Witte T. Aspects of innate immunity in Sjögren's syndrome. Arthritis Res Ther 2011, 13:218. 10.1186/ar3318, 21635716.
7. Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther 2011, 13:227. 10.1186/ar3348, 21745420.
8. Delaleu N, Nguyen CQ, Peck AB, Jonsson R. Sjögren's syndrome: studying the disease in mice. Arthritis Res Ther 2011, 13:217. 10.1186/ar3313, 21672284.
9. Ho PP, Lee LY, Zhao X, Tomooka BH, Paniagua RT, Sharpe O, BenBarak MJ, Chandra PE, Hueber W, Steinman L, Robinson WH. Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol 2010, 184:379-390. 10.4049/jimmunol.0901639, 19949094.
10. Diamond B, Bloom O, Al Abed Y, Kowal C, Huerta PT, Volpe BT. Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. J Intern Med 2011, 269:36-44. 10.1111/j.1365-2796.2010.02318.x, 3069637, 21158976.
11. Kallenberg CGM, Vissink A, Kroese FGM, Abdulahad WH, Bootsma H. What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?. Arthritis Res Ther 2011, 13:205. 10.1186/ar3234, 21371351.
12. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ, . EULAR Sjögren's Task Force EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011, 70:968-972. 10.1136/ard.2010.143743, 21345815, EULAR Sjögren's Task Force.